Clinical Trial

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Name: A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT — clinical trial record (NCT07061288)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2025-07-02; most recent amendment 2026-06-11.

Status change: Not Yet Recruiting → Recruiting 2025-09-24

Trial Details

NCT Number	NCT07061288
Lead Sponsor	Bristol-Myers Squibb
Conditions	Schizophrenia
Enrollment	116 participants
Start Date	2025-09-03
Primary Completion	2027-06-21 (estimated)
Study Completion	2027-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-12